Try our Advanced Search for more refined results
Life Sciences - January, 2012
198 articles
- Chile Fines 2 Pharmacy Chains $38M For Price Fixing
- Micromet Investor Sues To Halt $1.2B Amgen Purchase
- Generic Cancer Drug MDL Tossed In Light Of Mensing
- Winthrop & Weinstine Snares 6 Dorsey & Whitney IP Attys
- Omnicare Faces OT Class Action By Technicians, Others
- Enzo, Roche Square Off Over Medical Testing Patent
- Cadwalader Aids AngioDynamics In $372M Device Maker Buy
- Bayer Seeks to Block Pfizer's Bovine Drug With IP Suit
- Warner Chilcott Targeted Over Sales Reps' OT Pay
- Allergan, Merz Row Over Botox Secrets Headed To Trial
- Pfizer Wants Court To Pause Zoloft Birth Defects Suit
- AstraZeneca Sues Generics Maker Over Nexium Patents
- FDA Accused Of Spying On Employee Scientists' Emails
- Ex-Symmetry Medical Workers Consent To Fraud Claims
- J&J, Merck Take Heat Over L'Oreal Sunscreen Patents
- Drug Co. Valeant Walks Away From Bid for Ista
- Kilpatrick Brings Finnegan IP Whiz To Silicon Valley
- FTC Sues Omnicare To Block $441M PharMerica Merger
- Teva Unit Recalls Cancer Drug Treanda Over Glass Fragments
- Allergan Targets Hi-Tech Over IP For Glaucoma Generic
- FDA Reopens Comments On Drug Ad Rule In New Study's Wake
- Medtronic Hit With $10M Jury Verdict Over Catheter Patent
- Cooley Partner Takes GC Job At Jazz Pharmaceuticals
- BPA Class Certification: Denied
- Insurance Watchdog Investigating Lap-Band Centers: Aetna
- 5 Ways To Ramp Up Your Patent Portfolio
- EC Proceeds With Antitrust Probe Of French Drug Co.
- Jury Finds Varian Willfully Infringed Cancer Patent
- Affymetrix Suit Over Illumina Microarray IP Reopened
- AstraZeneca, Lupin Soothe Nexium Patent Fight
- Cordis Sues USPTO For Blocking Stent Re-Exam Subpoenas
- Pfizer Faces ERISA Stock-Drop Suit By Puerto Rico Workers
- Kreos Secures $160M For European Growth Fund
- Nestle Fires Back At Mead Johnson Over Bottle Design IP
- Graceway's Ch. 11 Plan Hinges On Asset Sale
- Celgene Snags Cancer Treatment Co. Avila For $350M
- Illumina Rebuffs $5.7B Roche Bid With Poison Pill
- Fed. Circ. Lifts Block On Generic Lovenox Sales
- A Health And Welfare Benefit Year In Review
- Ranbaxy Bows To Sweeping Penalties From US
- Sullivan Helps Amgen In $1.2B Micromet Buy
- Founder Of French Silicon Implant Co. Arrested Amid Scandal
- Forest Labs Bribed Study Authors To Boost Celexa: Suit
- Biotech Co. Affymetrix Pays $96M To End Investor Suit
- 4th Circ. Tosses Suit Over FDA-Approved Medtronic Device
- Cephalon Sues Mylan, Sandoz Again Over Generic Fentora
- Celgene, Novartis Chastised Over Cancer Drug Claims
- CPSC Proposes Child-Resistant Packages for Decongestants
- Covidien Makes Deal With Watson To Allow Generic Exalgo
- Takeda Hid Gout, GERD Drug Interactions: Whistleblower
- House Bill Targets High Court's Eminent Domain Ruling
- Forest Labs Derivative Suit Belongs In Federal Court: Atty
- Biosimilars Law In Limbo
- Substantial Guidance For The FDA's 510(k) Program
- Roche Launches $5.7B Hostile Bid For Illumina
- Pfizer Triumphs Over Drinkmaker In Viagra Mark Dustup
- Novartis To Settle Sales Reps' OT Claims For $99M
- Canada, Novartis Issue Warning On Blood Pressure Drugs
- Health Group Of The Year: Weil Gotshal & Manges
- APP Settles Patent Row Over Generic Blood Thinner
- EU Lawmakers Call For Tighter Controls On Breast Implants
- Bradley Arant Nabs Winston & Strawn Antitrust Atty
- Acura Settles Shareholder Claims Over Acurox For $1.5M
- Generics Cos. Fight Lovenox Injunction In Fed. Circ.
- Class Squashed In Beetle-Tainted Baby Formula Action
- Drug Co. Watson Grows Asian Presence With Ascent Buy
- Ex-McKinsey Exec's $40M Suit Against Fund Tossed
- CR Bard, Others Face Onslaught Of Surgical Mesh Suits
- St. Jude Awarded $27M In Vascular Closure Device IP Fight
- Venable Lures 3 IP Experts From Patton Boggs
- Lilly Sues Accord Over Generic Lung Cancer Drug Alimta
- Abbott Sues Generic Maker Over Cholesterol Drug Patent
- Health Group Of The Year: Ropes & Gray
- FDA Delays Decision on Alexza Antipsychotic Treatment
- Sandoz Targeted Over Generic Cancer Drug Fusilev
- FTC To Drop Antitrust Suit Over Lundbeck Heart Defect Drug
- FDA Panel Turns Down Columbia, Watson Preterm Birth Gel
- Proskauer Malpractice Suit Not Time-Barred: J&J Heir
- Meda Sues 2 Cos. Over Generic Nasal Spray Patent
- Wyeth, Cordis Stent Patents Are Invalid, Judge Says
- Health Group Of The Year: Covington & Burling
- Braintree, Buyers Settle Generic MiraLax Suit For $17M
- Dems Seek Probe Of Medical Device Cos.
- 11 Deaths Prompt EU Review Of Novartis Drug Gilenya
- Expert Testimony OK In Miscarriage Drug Suit: Judge
- Merck Unit, Pamlab Sue Over Generic Metafolin
- Health Care Group Of The Year: Arnold & Porter
- Charges Against Stryker, Sales Staff Dropped For $15M
- FDA Seeks More Info On Bristol, AstraZeneca Diabetes Drug
- Merck Closes Out Canadian Vioxx Claims For Up To $36.5M
- 4th Circ. Upholds GSK Win In Vaccine Contract Suit
- The Lowdown On Top Up Options
- Pfizer Seeks To Merge 59 Zoloft Birth Defect Suits
- J&J Settles Texas' Risperdal Suit For $158M
- Alnylam Claims Tekmira Infringed RNAi Tech Patents
- Covidien Recalls Chest Surgery Device After Patient Deaths
- 2nd Circ. Gave Undue FLSA Deference: NYC To High Court
- Feds Push For 1st Circ. To Reopen FCA Suit Against Pfizer
- Latham Woos Pharma IP Pro From Wilson Sonsini
- Stiefel Can't Shake ERISA, Fraud Claims Over GSK Buy
- Health Group Of The Year: Akin Gump
- Stryker To Pay $15M To End False Marketing Case
- Baker Botts Lures McDermott M&A Pros To Calif. Digs
- Cadwalader Scores Top Dealmaker From Cahill Gordon
- Asian Buyout Firm Takes $100M Stake In DM Healthcare
- 2nd Circ. Quashes Savient Investor's Class Action
- GSK Settles Bulk Of Avandia MDL Cases
- Ropes & Gray Can't Shake Patent Malpractice Suit
- Feds Drop Charges Against Stryker Sales Manager
- Ex-Sanofi Researcher Cops To Trade Secrets Theft
- FDA Fines Red Cross $9.6M For Continued Missteps
- Fresenius Targets Nostrum's Generic PhosLo GelCaps
- The FDA Crackdown On Health Care Provider Ads
- Merck Unit Sues To Block Teva's Generic Singulair
- Brain Infection Reports Prompt Boxed Warning On Adcetris
- The 10 Worst Drug/Medical Device Decisions Of 2011
- Fighting The Scourge Of Corruption
- McKesson's Bid To Revive Pill Dispenser IP Suit Nixed
- Lilly, 3rd-Party Payors Reach $4.5M Deal In Zyprexa Case
- Stryker Unit Settles Bone Staple Patent Suit
- Inhibitex Investor Sues To Block $2.5B Bristol-Myers Deal
- CVS To Pay $5M To End FTC's Deceptive Drug Price Claims
- Atty Accused Of Defaming 3M Asks To Toss Case
- Insurer Tries To Dodge Defending Avastin Distributor
- ITC Staff Sides With Merck In NuvaRing Patent Battle
- Walgreen, Par Schemed To Overcharge For Generics: Suit
- Meritain Accuses Express Scripts Of Client Data Theft
- More Countries Raise Alarm Over Faulty Breast Implants
- Perrigo Beats Reckitt Unit's Suit Over Generic Mucinex
- FDA Warns J&J Unit Over Insulin Pump Reporting Delays
- Clifford Chance Scores 2 Dewey & LeBoeuf M&A Pros
- Medtronic Asks Fed. Circ. To Nix Edwards' $74M IP Award
- Yellow Wood Unveils $225M Fund With Ropes & Gray's Help
- Novo Pays PE Firm $708M For Stake In Chr. Hansen
- Flagship Ventures Nets $270M For 4th VC Fund
- FDA Advisers On Yaz Had Ties To Bayer: Ex-Agency Chief
- Consumers Renew $29B Express Scripts, Medco Deal Fight
- FDA's Social Media Guidance Skirts Questions Of Liability
- CooperVision Hit With Investor Suit Over Lens Recall
- Boehringer Blood Thinner Linked To Heart Attacks: Study
- Vytorin Derivative Suit Settlement Wins Initial Nod
- Judge Severs Charges Against Former Stryker Head
- Calif. County's Sherman Act Claim Nixed In Plasma MDL
- Weil Reps Sanofi On $125M Biotech Venture With VCs
- Partnering With The Feds For IP Enforcement: Part 1
- Shire Hits Sandoz With 2nd Suit Over Generic Intuniv
- Conceptus Loses Injunction Bid In Contraceptive IP Fight
- Fed. Circ. Upholds Life Tech Injunction In Cell Patent Row
- Novartis Issues $120M Drug Recall, Plant Suspension
- Stryker Must Face Suit Over Joint Pain Pumps: Judge
- Bryan Cave Helps Sigma-Aldrich In $350M Deal
- SK Capital, IBA To Form $229M Medical Imaging Venture
- Drugmaker Valeant Losing Patience In $327M Hostile Bid
- Small Business Group Tells SEC To Relax Regulations
- Rite Aid Overcharges Drug Discount Plan Members: Suit
- Aisling Capital, Others Inject $48M Into Roka Bioscience
- CVS Pharmacists Dispense Wage Suit Over Travel Pay
- Philips Slaps Rival With New Defibrillator Patent Suit
- Vioxx MDL Attys Shut Out Of $950M DOJ Settlement
- Knowledge Is Power In Failure-To-Warn Claims
- Genzyme Wins Restrictions On Generic Arthritis Drug Price
- Abbott Gets Claim Cut From Baby Formula Bugs Suit
- A Model For Olympus Shareholder Litigation
- J&J To Pay $1B To Settle Risperdal Civil Claims: Report
- Whirlpool Latest Target In Navy Encryption Patent Blitz
- Kaye Scholer Nabs Ex-Frommer Lawrence IP Pro
- Takeda, Watson Sue Mylan Over Generic Actoplus Met XR
- Scottish Equity Partners Closes New $310M Fund
- The Latest On Off-Label Responses
- Actavis Pays $118M To Settle Drug Pricing Claims
- FDA Restricts Antibiotic Use In Food Animals
- Ex-Cephalon GC Joins Morgan Lewis Litigation Group
- Fired Wyeth Employee Spoke Up Too Late: 2nd Circ.
- Pfizer Unit's Skelaxin Pay-For-Delay Deal Illegal: Suit
- FDA Orders Bard, Others To Study Surgical Mesh Implants
- ITC Denies Sanctions Bid In NuvaRing Patent Row
- Pfizer Must Pay $45M In Menopause Drug Suits: Pa. Court
- Abbott Drops Patent Claims Over Teva's Generic Simcor
- DOJ's Emphasis On FCA Cases In 2011
- J&J Investors Renew Push For CEO Liability In Recalls
- Ex-McKesson Worker Files Pay, Seating Class Action
- Reed Smith Reps Essex In $118M Biologics Deal
- FDA Seeks To Streamline Medical Device Approvals
- 9th Circ. Puts Lid On Actimmune Marketing Action
- Spire Settles With Catheter Co. Over Recall, Deal Bungle
- AstraZeneca's Symbicort Inhaler Triggers Patent Suit
- Fed. Circ. Backs $5M Cordis Award In Stent Patent Suit
- DC Circ. Snuffs Out Suit Over FDA's Ear Candle Warnings
- Varian Found To Infringe University's Radiation Patent
- Regeneron Strikes Deal With Genentech To Market Eylea
- Merck Canada Sues To Block Mylan's Generic Singulair
- Black & Decker, Others To Sweep Up RI Waste Site
- Competition Cases To Watch In 2012
- Product Liability Cases To Watch In 2012
- Product Liability Regulation To Watch In 2012
- Employment Cases To Watch In 2012
- IP Cases To Watch In 2012
- Trends In M&A In 2012